Related Experiment Videos
Myeloproliferative disorders--neurological complications
J S Tarach1, B M Nowicka-Tarach
12nd Department and Clinic of Internal Medicine, Medical University, ul. Jaczewskiego 8, 20-090 Lublin, Poland.
Abstract:
Primary myeloproliferative disorders (MPD) are often associated with hemostasis abnormalities, which may cause many thrombotic or hemorrhagic complications during the course of the disease. Clinical consequences following abnormal hemostatic conditions include various neurological manifestations. It is extremely difficult to predict and evaluate the risk and chance, that MPD patients will develop neurological symptoms. The up-to-date background of pathological thrombocytosis, as well as the neurological aspects of abnormal hemostasis during the course of myeloproliferative disorders have been reviewed in this study.
Insights
Primary myeloproliferative disorders (MPD) can cause hemostasis issues, leading to thrombotic or hemorrhagic complications and neurological symptoms. Predicting these neurological risks in MPD patients remains challenging.
Area of Science:
- Hematology
- Neurology
- Thrombosis Research
Background:
- Primary myeloproliferative disorders (MPD) are linked to hemostasis abnormalities.
- These abnormalities can result in thrombotic and hemorrhagic complications.
- Neurological manifestations are significant clinical consequences of abnormal hemostasis in MPD.
Purpose of the Study:
- To review the current understanding of pathological thrombocytosis in MPD.
- To explore the neurological aspects associated with abnormal hemostasis in MPD.
- To highlight the challenges in predicting neurological complications in MPD patients.
Main Methods:
- Literature review of pathological thrombocytosis.
- Analysis of neurological manifestations in MPD patients.
- Review of hemostasis abnormalities in myeloproliferative disorders.
Main Results:
- MPD frequently presents with hemostasis abnormalities.
- Neurological symptoms are a common complication of these hemostatic issues.
- Risk assessment for neurological symptoms in MPD is complex and difficult.
Conclusions:
- Hemostasis abnormalities in MPD significantly contribute to thrombotic and hemorrhagic events.
- Neurological complications are a critical concern in the management of MPD.
- Further research is needed to improve the prediction and management of neurological risks in MPD.